Company
Medpace Holdings, Inc.
Headquarters: Cincinnati, OH, United States
Founded: 1992
Employees: 4,500
CEO: Dr. August James Troendle M.D.
Market Cap
$10.81 Billion
USD as of Jan. 1, 2025
Medpace Holdings, Inc. Categories
United States Healthcare Diagnostics & ResearchUnited States Healthcare United States Diagnostics & Research
Top Competitors by Market Capitalization
Industry: Diagnostics & Research
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $219.88 B |
| Danaher | $177.43 B |
| Siemens Healthineers AG | $59.19 B |
| Agilent Technologies, Inc. | $43.57 B |
| Lonza Group Ltd | $41.66 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | $2.07 B |
| EBITDA | $439.7 M |
| Gross Profit TTM | $1.39 B |
| Profit Margin | 17.66% |
| Operating Margin | 21.05% |
| Quarterly Revenue Growth | 8.30% |
Stocks & Indices
Medpace Holdings, Inc. has the following listings and related stock indices.
Stock: NASDAQ: MEDP wb_incandescent
Stock: BMV: MEDP wb_incandescent
Stock: FSX: 01P wb_incandescent
Product & Services
Support services for pharmaceutical and medical device
Key People
Dr. August J. Troendle, President and CEO